Results 121 to 130 of about 5,463 (188)

Long-term outcomes of surgical treatment of cervical spine involvement in rheumatoid arthritis. [PDF]

Int Orthop
Combalia A, Salvà-Servera AL, Muñoz-Mahamud E.   +2 more
europepmc   +1 more source

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results. [PDF]

JCO Oncol Adv
Slotkin EK, Mauguen A, Dela Cruz FS, Ortiz MV, Avutu V, Meyers PA, Wexler LH, O'Donohue TJ, Kinnaman MD, Kelly CM, D'Angelo SP, Keohan ML, Gounder MM, Thornton K, Nacev BA, Chi P, Rosenbaum E, Dickson M, Pachhal S, Somwar R, Ladanyi M, Robb C, Pandit-Taskar N, Hwang S, Price A, Behr G, Reed DR, Kentsis A, Kung AL, Bender JG, Tap WD.   +30 more
europepmc   +1 more source

Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets. [PDF]

JCO Precis Oncol
Wagner MJ, Pimenta EM, Sweeney NW, Loggers ET, Roberts JL, Brinkman E, Chen EY, Ricciotti R, Haddox CL, Berg R, Yilma B, Stoppler MC, Chen JL, Cranmer LD.   +13 more
europepmc   +1 more source

Incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device. [PDF]

Indian J Ophthalmol
Senthilkumar VA, Akbar US, Rajendrababu S.   +2 more
europepmc   +1 more source

Data telemetry systems to access climate sensitive data from moored instrumentation [PDF]

, 2011
Busack, M., Karstensen, Johannes, Oesterhus, S., Pinck, Andreas, Visbeck, Martin   +4 more
core  

Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US. [PDF]

PLoS One
Castellano T, ElHabr AK, Washington C, Ting J, Zhang YJ, Musa F, Berksoy E, Moore K, Randall L, Chhatwal J, Ayer T, Leath CA.   +11 more
europepmc   +1 more source

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma. [PDF]

ESMO Open
Rosenbaum E, Seier K, Bradic M, Movva S, Kelly CM, Dickson MA, Keohan ML, Gounder MM, Chi P, Nacev BA, Chan JE, Avutu V, Biniakewitz M, Jasnani S, Duchemin M, Desir R, Wong P, Erinjeri J, Hwang S, Antonescu CR, Qin LX, Tap WD, D'Angelo SP.   +22 more
europepmc   +1 more source

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. [PDF]

Gynecol Oncol
Washington C, Dwivedi SKD, Gunderson-Jackson C, Walker J, Mannel RS, Holman LL, Richardson DL, Neelakantan D, Cohoon A, Ding K, Gatalica Z, Moxley KM, Landrum LM, Rowland MR, Bhattacharya R, Moore KN.   +15 more
europepmc   +1 more source

Interaction Between Age and Tumor Stage in Survival Outcomes of Patients With Mantle Cell Lymphoma. [PDF]

J Community Hosp Intern Med Perspect
Bangolo A, Amoozgar B, Nagesh VK, McGrath K, Mallipeddi S, Cash S, Sandilya A, Banu R, Martine FR, Gill S, Zhang L, Naeem S, Mallampalli P, Ram A, Papantoniou D, Nareeba S, Baek K, Sharma U, Mondal G, Bano K, Gad M, Rokade PR, Kharat MM, Dodhia A, Goud S, Gavva S, Aduna EG, Siddiqui ZS, Palvia AR, Singh A, Nayak A, Jakkula KP, Jethi A, Thota N, Weissman S.   +34 more
europepmc   +1 more source

A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations. [PDF]

ESMO Open
Ródon J, Arkenau HT, Funchain P, Hervieu A, Anthony K, Chawla SP, Laetsch TW, Murciano-Goroff YR, Singer CF, He Y, Mina M, Wacheck V, Delaloge S.   +12 more
europepmc   +1 more source